Tryp Therapeutics Announces $2,000,000 Financing and Changes in Management, Board of Directors
Ryan Allway February 4th, 2022 Psychedelics, Top News SAN DIEGO – February 4, 2022 – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company“), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, is pleased to announce a non-brokered private placement (the “Placement“)... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )